当前位置: 首页 > 详情页

Long-term outcome of native artery versus bypass graft intervention in prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction

文献详情

资源类型:

收录情况: ◇ SCIE ◇ 统计源期刊 ◇ CSCD-C ◇ 中华系列

机构: [1]Capital Med Univ, Beijing An Zhen Hosp, Dept Cardiol, Beijing 100029, Peoples R China; [2]Univ Texas Med Branch, Div Cardiol, Dept Internal Med, Galveston, TX 77555 USA
出处:
ISSN:

关键词: coronary artery bypass graft percutaneous coronary intervention acute myocardial infarction

摘要:
Background Patients with prior coronary artery bypass graft (CABG) have a poor outcome after acute myocardial infarction (AMI).Little is known about the treatment strategy and outcome of percutaneous coronary intervention (PCI) in these patients.The purpose of this study was to investigate the impact of graft versus native artery PCI on the outcomes of prior CABG patients with AMI.Methods Between September 2005 and October 2011,a total of 140 consecutive patients with previous CABG undergoing PCI for the treatment of AMI were included.Clinical/procedural characteristics and long-term clinical outcomes were compared between graft and native artery PCI patients.Results The mean time interval to prior CABG was (5.6±4.2) years.Thirty patients received graft PCI,success rate being 90%.One hundred and ten patients received native artery PCI,success rate being 90.7% (P >0.05).There were no significant differences in the basic characteristics between the two groups.All patients received drug eluting stents (DESs).Three patients died during hospitalization in the graft-PCI group (10% vs.native PCI 0,P <0.05).After a median followup of two years,major adverse cardiac events (MACE) (myocardial infarction,target vessel revascularization,total death) were 20% with no significant difference between the two groups.Cox regression analysis showed that both diabetes mellitus (DM,HR 3.57,95% CI 1.03-5.75,P <0.05) and primary PCI (HR 5.932,95% Cl 1.91-18.4,P <0.05) were independent predictors of MACE.Conclusions More patients with prior CABG underwent native artery PCI for AMI.PCI to culprit graft vessels had higher in-hospital mortality.DM and primary PCI,but not graft PCI,were predictors for adverse long-term outcome.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:内科
JCR分区:
出版当年[2011]版:
Q3 MEDICINE, GENERAL & INTERNAL
最新[2024]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2024版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

[1]Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction [2]Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18-45 Years with Diabetes Mellitus [3]Meta-analysis of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with diabetes and left main and/or multivessel coronary artery disease [4]Meta-analysis of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Patients with Diabetes and Left Main and/or Multivessel Coronary Artery Disease [5]Long term outcomes of saphaneous vein graft intervention in elderly patients with prior coronary artery bypass graft [6]有冠状动脉旁路移植术史的急性心肌梗死患者经皮冠状动脉介入治疗的临床预后 [7]The Incidence and Risk Factors of Acute Asymptomatic Brain Infarcts After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction [8]Beneficial effect of adenosine on myocardial perfusion in patients treated with primary percutaneous coronary intervention for acute myocardial infarction [9]Comparison of Left and Right Radial Approach for Primary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction Patients [10]Association between admission fasting plasma glucose and contrast-induced nephropathy in elderly acute myocardial infarction patients undergoing percutaneous coronary intervention

资源点击量:18307 今日访问量:0 总访问量:1009 更新日期:2025-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院